Three insights:
1. The Ti3Z Interbody System is to be used at either one or two levels in the lumbar spine.
2. The device is intended to treat degenerative disc disease with up to Grade I spondylolisthesis after patients have had six months of failed non-operative treatment.
3. The titanium implants have an internal porous structure and an external solid surface developed to engage with the vertebral body end plates.
“The interior lattice structure promotes osseointegration and optimal elasticity, while the external edges of the implant maintains mechanical stability,” said Jeffrey Johnson, CEO of Zavation.
More articles on surface technology:
Anika to showcase hyaluronic acid-based cartilage repair scaffold
4 key updates in surface technology for spine
Alphatec launches new titanium interbody implant for spine – 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
